-
1 Comment
C-MER Eye Care Holdings Limited is currently in a long term uptrend where the price is trading 45.1% above its 200 day moving average.
From a valuation standpoint, the stock is 90.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.6.
C-MER Eye Care Holdings Limited's total revenue sank by 16.0% to $262M since the same quarter in the previous year.
Its net income has dropped by 373.3% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 107.7% to $11M since the same quarter in the previous year.
Based on the above factors, C-MER Eye Care Holdings Limited gets an overall score of 3/5.
| CurrencyCode | HKD |
|---|---|
| Exchange | HK |
| ISIN | KYG2R51A1053 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 2B |
|---|---|
| Beta | 0.78 |
| PE Ratio | None |
| Target Price | 4.5 |
| Dividend Yield | None |
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China other business. The company provides oncology, medical aesthetics, general practice, ophthalmic, dental, and other medical services; cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services; and medical consumables. It also engages in the sale of vision aid products, such as glasses and lens. The company was formerly known as C-MER Eye Care Holdings Limited and changed its name to C-MER Medical Holdings Limited in June 2024. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Medical Holdings Limited is a subsidiary of C-MER Group Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3309.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
